There's a new development in the fight against the pandemic. A serological test for COVID-19 in Canada has been approved and it will be the first of its kind to be used here. This could help us understand immunity to the virus.\nHealth Canada authorized the country's first test to detect COVID-19 antibodies on May 12 after a priority scientific review.\nThis test is called the DiaSorin LIAISON.\nWith the approval of it, Canadian laboratories will use the DiaSorin LIAISON to detect antibodies that are specific to COVID-19 in hopes of learning more about immunity.\nSerological tests help give a better understanding of whether people who have already had the virus are immune to it.\nMore research will also provide knowledge about the relationship between positive tests for antibodies and protection against re-infection.\nAt least one million blood samples from people in this country will be collected and tested over the next two years as part of the government's response to the pandemic.\nAll of that testing will be done under the leadership of Canada's COVID-19 Immunity Task Force which includes Dr. Theresa Tam.\nThis work will help track the virus among the general population and specific groups that are at higher risk of getting it like seniors and healthcare workers.\nView this post on Instagram You have probably heard people talking about serological tests for the coronavirus epidemic. Check out the blog on our website (link in bio and search serological assay importance) where Dr. Ashley Anderson, Chief Medical Officer at Promega explains what serological assays are and how they help inform the pandemic response.. . . . . #Coronavirus #Covid19 #assays #serologicaltests #PCR #qPCR #reagents #Labwork #LabChat #Corona #scientists #viraldiseases #biologists #assaydevelopment #assay #nucleicacid #researchlabs #phdchat #laboratorywork #assays #science #biology #instascience #instabiology #microbiology #biotech #phdstudentsofinstagram #Promega #serologicalassay #serologicaltests A post shared by Promega UK (@promega_uk) on Apr 9, 2020 at 9:16am PDT\nThe task force was first announced by Justin Trudeau back on April 23 when he introduced the country's three-pillar plan to defeat the virus.\nThose pillars are research on vaccines and other treatments, supports for clinical trials, and expanding national testing and modelling.\nAll of those measures equal to $1.1 billion of funding.\nThe task force will also look to figure out how many people here have been infected beyond those who were tested.\nSpeaking in Ottawa, Prime Minister Justin Trudeau announces funding for #COVID19 research and testing:—$115M for research into vaccines & treatments—$662M for clinical trials—$350M to expand national testing & modelling, including creation of immunity task force#cdnpoli pic.twitter.com/NzTYGYVDsF— CPAC (@CPAC_TV) April 23, 2020\n"Understanding the scope and scale of COVID-19 infections across the country is key to managing the epidemic over the coming months," Health Canada stated.\nThat will also help inform public health decisions.\nSo far, Health Canada has authorized 18 diagnostic testing devices for COVID-19 which include ones used to detect active infection.